139 related articles for article (PubMed ID: 32579550)
1. Signature genes associated with immunological non-responsiveness to anti-retroviral therapy in HIV-1 subtype-c infection.
Singh S; Toor JS; Sharma A; Arora SK
PLoS One; 2020; 15(6):e0234270. PubMed ID: 32579550
[TBL] [Abstract][Full Text] [Related]
2. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
[TBL] [Abstract][Full Text] [Related]
3. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
5. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
Gene; 2020 May; 741():144568. PubMed ID: 32165289
[TBL] [Abstract][Full Text] [Related]
6. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
Carsenti-Dellamonica H; Saïdi H; Ticchioni M; Guillouet de Salvador F; Dufayard Cottalorda J; Garraffo R; Dellamonica P; Durant J; Gougeon ML
HIV Med; 2011 Feb; 12(2):65-77. PubMed ID: 20500532
[TBL] [Abstract][Full Text] [Related]
7. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
8. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
10. Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
Bart PA; Rizzardi GP; Tambussi G; Chave JP; Chapuis AG; Graziosi C; Corpataux JM; Halkic N; Meuwly JY; Munoz M; Meylan P; Spreen W; McDade H; Yerly S; Perrin L; Lazzarin A; Pantaleo G
AIDS; 2000 Sep; 14(13):1887-97. PubMed ID: 10997391
[TBL] [Abstract][Full Text] [Related]
11. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
[TBL] [Abstract][Full Text] [Related]
12. NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy.
Sennepin A; Baychelier F; Guihot A; Nel I; Ho Tsong Fang R; Calin R; Katlama C; Simon A; Crouzet J; Debré P; Vieillard V
AIDS; 2013 Jul; 27(12):1857-66. PubMed ID: 24179999
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders.
Magen E; Elbirt D; Agmon-Levin N; Mishal J; Sthoeger Z
Int J Infect Dis; 2010 Apr; 14(4):e322-7. PubMed ID: 19699671
[TBL] [Abstract][Full Text] [Related]
14. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
15. Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
Soria A; Trabattoni D; Squillace N; Rainone V; Gnudi F; Clerici M; Gori A; Bandera A
PLoS One; 2015; 10(2):e0117118. PubMed ID: 25671649
[TBL] [Abstract][Full Text] [Related]
16. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
[TBL] [Abstract][Full Text] [Related]
17. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
[TBL] [Abstract][Full Text] [Related]
18. Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART).
Torti C; Cologni G; Uccelli MC; Quiros-Roldan E; Imberti L; Airó P; Pirovano S; Patroni A; Tirelli V; Carosi G
Viral Immunol; 2004; 17(2):279-86. PubMed ID: 15279705
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
d'Ettorre G; Forcina G; Lichtner M; Mengoni F; D'Agostino C; Massetti AP; Mastroianni CM; Vullo V
AIDS; 2002 Jan; 16(2):181-8. PubMed ID: 11807301
[TBL] [Abstract][Full Text] [Related]
20. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
